Kestra Advisory Services, LLC Biomarin Pharmaceutical Inc Transaction History

Kestra Advisory Services, LLC

$17.3 Billion
Q3 2024

A detailed history of Kestra Advisory Services, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 9,754 shares of BMRN stock, worth $649,909. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,754

Previous 9,134 6.79%

Holding current value

$649,909

Previous $752,000 8.91%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$69.02 - $93.84 $42,792 - $58,180	620 Added 6.79%	9,754 $685,000
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $688,551 - $853,127	-9,251 Reduced 50.32%	9,134 $752,000
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $259,391 - $306,405	3,095 Added 20.24%	18,385 $1.61 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $110,976 - $143,430	1,456 Added 10.52%	15,290 $1.47 Million
Q3 2023 Nov 09, 2023	BUY	$85.07 - $94.48 $239,642 - $266,150	2,817 Added 25.57%	13,834 $1.22 Million
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $61,716 - $71,413	712 Added 6.91%	11,017 $954,000
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $48,958 - $65,436	558 Added 5.72%	10,305 $1 Million
Q4 2022 Jan 31, 2023	BUY	$80.93 - $108.63 $242,870 - $325,998	3,001 Added 44.49%	9,747 $1.01 Million
Q3 2022 Nov 01, 2022	BUY	$82.16 - $96.94 $36,889 - $43,526	449 Added 7.13%	6,746 $572 Million
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $122,516 - $148,860	-1,714 Reduced 21.4%	6,297 $522,000
Q1 2022 Apr 26, 2022	BUY	$74.28 - $92.69 $317,695 - $396,435	4,277 Added 114.54%	8,011 $617,000
Q4 2021 Jan 20, 2022	SELL	$71.72 - $91.47 $16,997 - $21,678	-237 Reduced 5.97%	3,734 $329,000
Q3 2021 Oct 19, 2021	BUY	$74.77 - $85.47 $22,431 - $25,641	300 Added 8.17%	3,971 $306,000
Q2 2021 Jul 28, 2021	BUY	$75.51 - $84.79 $30,808 - $34,594	408 Added 12.5%	3,671 $306,000
Q1 2021 May 10, 2021	BUY	$74.73 - $90.69 $243,843 - $295,921	3,263 New	3,263 $246,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Biomarin Pharmaceutical Inc Transaction History